A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection
Public ClinicalTrials.gov record NCT06746883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Single-arm, Open-label, Prospective, Observational Study to Assess the Safety of Sulbactam-durlobactam, Including the Risk of Hypersensitivity Reactions (Including Anaphylaxis) in Participants With Acinetobacter Baumannii-calcoaceticus Complex Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of this observational study is to evaluate the safety of sulbactam-durlobactam, as well as the risk of hypersensitivity reactions (including anaphylaxis) in participants with Acinetobacter baumannii-calcoaceticus complex infection. Participants will be followed for approximately 28 days in order to collect safety and reaction data.
Study identification
- NCT ID
- NCT06746883
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 100 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 27, 2025
- Primary completion
- Jan 30, 2029
- Completion
- Jan 30, 2029
- Last update posted
- Jun 23, 2026
2025 – 2029
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Davis Health | Sacramento | California | 95817 | Recruiting |
| University of Florida - Gainesville | Gainesville | Florida | 32610-3003 | Recruiting |
| Tampa General Hospital | Tampa | Florida | 33606 | Recruiting |
| University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd | Kansas City | Kansas | 66160 | Recruiting |
| University of Kentucky College of Medicine | Lexington | Kentucky | 40536-7001 | Recruiting |
| Ochsner Medical Center - New Orleans | New Orleans | Louisiana | 70121-2429 | Recruiting |
| Ochsner LSU Health Science Center Shreveport | Shreveport | Louisiana | 71103-4228 | Recruiting |
| Montefiore Medical Group Family Care Center | The Bronx | New York | 10467-2410 | Recruiting |
| Summa Health System - Akron - 75 Arch Street | Akron | Ohio | 44304-1430 | Recruiting |
| The Carl and Edyth Lindner Center for Research and Education at Christ Hospital | Cincinnati | Ohio | 45219 | Recruiting |
| University of Pittsburg School of Medicine | Pittsburgh | Pennsylvania | 15213-2500 | Recruiting |
| Prisma Health - Infectious Diseases - Greenville | Greenville | South Carolina | 29605 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06746883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06746883 live on ClinicalTrials.gov.